Biophan Acquires Two MRI Companies

Biophan Technologies, a developer of next-generation medical technology, has announced the filing of an SEC Form 8K/A report detailing its acquisition of technology innovators aMRIs and MR Comp, two German companies conducting research and development in advanced technologies involving magnetic resonance imaging (MRI). Under the terms of the transaction, disclosed in the SEC Form 8K/A, Biophan acquired 51 percent of aMRIs, while aMRIs acquired 58.4 percent ownership of MR Comp.

Advanced Imaging Pro (http://www.advancedimagingpro.com/article/article.jsp?siteSection=3&id=900)